| My Account | Subscribe | Contact Us | Help |
Home
Diabetes Health
Diabetes Health Professional
- Sixth Annual Product Reference Guide
Our Sixth Annual Product Reference Guide contains 11 charts with over 300 products. You’ll find the guide is useful all year long. Use it whenever you’re contemplating a change in your diabetes care products.
- Insulin
- Insulin Pens
- Insulin Pen Needles
- Insulin Pumps
- Infusion Sets
- Continuous Glucose Monitors
- Blood Glucose Meters
- Type 2 Medications
- Fast-Acting Products
- Lancing Devices
- Syringes
The must-have resource for physicians, educators and medical professionals who focus on the treatment of diabetes.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
Latest Type 2 Medications Articles
Warning About Byetta and Pancreatitis
5 November 2007
The FDA has received thirty reports of acute pancreatitis (rapid-onset inflammation of the pancreas) in type 2 patients taking Byetta. Twenty-seven of the thirty patients had one or more risk factors for acute pancreatitis, such as gallstones or alcohol use.
In six patients, the pancreatitis symptoms began or worsened after the dose of Byetta was doubled. Twenty-two of the thirty improved after discontinuing Byetta, and three worsened again after Byetta was re-started.
As a result of these reports, the FDA is asking Amylin, the drug's maker, to add a warning about pancreatitis to the "Precautions" section of the drug's label. The agency is advising Byetta-taking patients to seek medical care if they have unexplained persistent abdominal pain, possibly accompanied by vomiting. Physicians are also being instructed to discontinue Byetta if pancreatitis is suspected.
Source: Medpage Today
Share on Facebook
Share on MySpace 
Share on Digg
You May Also Be Interested In...
147 comments - 29 Nov 2007
117 comments - 25 Dec 2008
82 comments - 25 Dec 2008
57 comments - 25 Dec 2008
Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register..
Register your Diabetes Health Username here.
Have Your Say...